284 related articles for article (PubMed ID: 26473782)
1. A combinatorial radiographic phenotype may stratify patient survival and be associated with invasion and proliferation characteristics in glioblastoma.
Rao A; Rao G; Gutman DA; Flanders AE; Hwang SN; Rubin DL; Colen RR; Zinn PO; Jain R; Wintermark M; Kirby JS; Jaffe CC; Freymann J;
J Neurosurg; 2016 Apr; 124(4):1008-17. PubMed ID: 26473782
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
[TBL] [Abstract][Full Text] [Related]
4. A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome.
Chaddad A; Desrosiers C; Hassan L; Tanougast C
Br J Radiol; 2016 Dec; 89(1068):20160575. PubMed ID: 27781499
[TBL] [Abstract][Full Text] [Related]
5. Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma.
Grossmann P; Gutman DA; Dunn WD; Holder CA; Aerts HJ
BMC Cancer; 2016 Aug; 16():611. PubMed ID: 27502180
[TBL] [Abstract][Full Text] [Related]
6. A novel volume-age-KPS (VAK) glioblastoma classification identifies a prognostic cognate microRNA-gene signature.
Zinn PO; Sathyan P; Mahajan B; Bruyere J; Hegi M; Majumder S; Colen RR
PLoS One; 2012; 7(8):e41522. PubMed ID: 22870228
[TBL] [Abstract][Full Text] [Related]
7. Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme.
Zinn PO; Mahajan B; Sathyan P; Singh SK; Majumder S; Jolesz FA; Colen RR
PLoS One; 2011; 6(10):e25451. PubMed ID: 21998659
[TBL] [Abstract][Full Text] [Related]
8. MGSEA - a multivariate Gene set enrichment analysis.
Tiong KL; Yeang CH
BMC Bioinformatics; 2019 Mar; 20(1):145. PubMed ID: 30885118
[TBL] [Abstract][Full Text] [Related]
9. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.
Gevaert O; Mitchell LA; Achrol AS; Xu J; Echegaray S; Steinberg GK; Cheshier SH; Napel S; Zaharchuk G; Plevritis SK
Radiology; 2014 Oct; 273(1):168-74. PubMed ID: 24827998
[TBL] [Abstract][Full Text] [Related]
12. Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project.
Colen RR; Vangel M; Wang J; Gutman DA; Hwang SN; Wintermark M; Jain R; Jilwan-Nicolas M; Chen JY; Raghavan P; Holder CA; Rubin D; Huang E; Kirby J; Freymann J; Jaffe CC; Flanders A; ; Zinn PO
BMC Med Genomics; 2014 Jun; 7():30. PubMed ID: 24889866
[TBL] [Abstract][Full Text] [Related]
13. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time.
Liao X; Cai B; Tian B; Luo Y; Song W; Li Y
J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929
[TBL] [Abstract][Full Text] [Related]
14. A robust two-gene signature for glioblastoma survival prediction.
Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
[TBL] [Abstract][Full Text] [Related]
15. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR
Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations associated with MRI-derived volumetric features in glioblastoma.
Gutman DA; Dunn WD; Grossmann P; Cooper LA; Holder CA; Ligon KL; Alexander BM; Aerts HJ
Neuroradiology; 2015 Dec; 57(12):1227-37. PubMed ID: 26337765
[TBL] [Abstract][Full Text] [Related]
17. Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.
Lu J; Cowperthwaite MC; Burnett MG; Shpak M
PLoS One; 2016; 11(4):e0154313. PubMed ID: 27124395
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma: imaging genomic mapping reveals sex-specific oncogenic associations of cell death.
Colen RR; Wang J; Singh SK; Gutman DA; Zinn PO
Radiology; 2015 Apr; 275(1):215-27. PubMed ID: 25490189
[TBL] [Abstract][Full Text] [Related]
19. Semantic imaging features predict disease progression and survival in glioblastoma multiforme patients.
Peeken JC; Hesse J; Haller B; Kessel KA; Nüsslin F; Combs SE
Strahlenther Onkol; 2018 Jun; 194(6):580-590. PubMed ID: 29442128
[TBL] [Abstract][Full Text] [Related]
20. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
Niyazi M; Pitea A; Mittelbronn M; Steinbach J; Sticht C; Zehentmayr F; Piehlmaier D; Zitzelsberger H; Ganswindt U; Rödel C; Lauber K; Belka C; Unger K
Oncotarget; 2016 Jul; 7(29):45764-45775. PubMed ID: 27302927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
